Cancer patients going through treatment have to deal with almost a dozen different side effects, each one flaring up at random. Enna Health helps cancer patients track those symptoms, understand the patterns and take proactive measures to address them.
About Chemo Symptom Tracker by Enna Health on Product Hunt
“Proactively track & manage cancer treatment side effects”
Chemo Symptom Tracker by Enna Health launched on Product Hunt on July 20th, 2022 and earned 62 upvotes and 6 comments, placing #35 on the daily leaderboard. Cancer patients going through treatment have to deal with almost a dozen different side effects, each one flaring up at random. Enna Health helps cancer patients track those symptoms, understand the patterns and take proactive measures to address them.
Chemo Symptom Tracker by Enna Health was featured in Tech (622.1k followers), Medical (3.4k followers) and Health (6.4k followers) on Product Hunt. Together, these topics include over 170k products, making this a competitive space to launch in.
Who hunted Chemo Symptom Tracker by Enna Health?
Chemo Symptom Tracker by Enna Health was hunted by Abdullah Abdulkareem. A “hunter” on Product Hunt is the community member who submits a product to the platform — uploading the images, the link, and tagging the makers behind it. Hunters typically write the first comment explaining why a product is worth attention, and their followers are notified the moment they post. Around 79% of featured launches on Product Hunt are self-hunted by their makers, but a well-known hunter still acts as a signal of quality to the rest of the community. See the full all-time top hunters leaderboard to discover who is shaping the Product Hunt ecosystem.
Reviews
Chemo Symptom Tracker by Enna Health has received 1 review on Product Hunt with an average rating of 5.00/5. Read all reviews on Product Hunt.
Want to see how Chemo Symptom Tracker by Enna Health stacked up against nearby launches in real time? Check out the live launch dashboard for upvote speed charts, proximity comparisons, and more analytics.
Abdullah Abdulkareem